Malignant osteopetrosis: c-src kinase is not reduced in fibroblasts

Calcif Tissue Int. 1993 Jul;53(1):69-70. doi: 10.1007/BF01352018.

Abstract

Targeted disruption of the c-src gene leads to a severe form of osteopetrosis in mice [2]. As the c-src gene is expressed in all tissues and cells tested, we have analyzed fibroblasts from three individuals with malignant, congenital osteopetrosis for the expression of c-src at the protein level. No differences could be detected in c-src protein and c-src kinase activity levels between fibroblasts from healthy controls and affected individuals. Thus, impairment of c-src function as an etiological factor in human osteopetrosis appears unlikely in the individuals investigated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CSK Tyrosine-Protein Kinase
  • Cells, Cultured
  • Electrophoresis, Polyacrylamide Gel
  • Fibroblasts / chemistry
  • Fibroblasts / enzymology*
  • Humans
  • Osteopetrosis / enzymology*
  • Osteopetrosis / genetics
  • Precipitin Tests
  • Protein-Tyrosine Kinases / metabolism*
  • Proto-Oncogene Proteins pp60(c-src) / analysis
  • src-Family Kinases

Substances

  • Protein-Tyrosine Kinases
  • CSK Tyrosine-Protein Kinase
  • Proto-Oncogene Proteins pp60(c-src)
  • src-Family Kinases
  • CSK protein, human